Showing results (21-30 of 127) with videos related to
Sort By:
Pageof 13
Interactive Cardiovascular and Thoracic Surgery|June 14, 2022
Strategy for lung parenchyma-sparing bronchial resection: a case series reportAkihiro Ohsumi, Hidenao Kayawake, Yoshito Yamada, et al.Journal of Radiation Research|July 12, 2022
Propensity score-based analysis of stereotactic body radiotherapy, lobectomy and sublobar resection for stage I non-small cell lung cancerNoriko Kishi, Yukinori Matsuo, Toshi Menju, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 26, 2014
Virtual-assisted lung mapping: outcome of 100 consecutive cases in a single instituteMasaaki Sato, Tetsu Yamada, Toshi Menju, et al.JTCVS Techniques|December 13, 2024
Extended segmentectomy for intersegmental lesions with intraoperative surgical margin assessment by radiofrequency identification markersYojiro Yutaka, Shigeto Nishikawa, Satona Tanaka, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 30, 2024
Location of Fibroblastic Foci: Does the Lesion You Observe Really Suggest Usual Interstitial Pneumonia?Hiroyuki Katsuragawa, Hiroaki Ito, Tomohiro Handa, et al.Histopathology|July 29, 2016
Adipophilin expression in lung adenocarcinoma is associated with apocrine-like features and poor clinical prognosis: an immunohistochemical study of 328 casesMasakazu Fujimoto, Akihiko Yoshizawa, Shinji Sumiyoshi, et al.General Thoracic and Cardiovascular Surgery|January 28, 2021
Efficacy of three-dimensional computed tomography volumetry for recipients in downsizing oversized grafts in brain-dead donor lung transplantationRyo Fujimoto, Daisuke Nakajima, Satona Tanaka, et al.Surgery Today|January 18, 2022
High programmed death ligand 1 expression in carcinomatous components predicts a poor prognosis in pulmonary pleomorphic carcinomaMisa Noguchi, Toshi Menju, Naoki Nakajima, et al.General Thoracic and Cardiovascular Surgery|February 22, 2023
Outcomes of immune checkpoint inhibitors for postoperative recurrence of non-small cell lung cancerItsuki Yuasa, Masatsugu Hamaji, Hiroaki Ozasa, et al.Cancer Management and Research|January 27, 2025
ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 Inversely Regulates Programmed Death-Ligand 1 Through Negative Feedback of Phosphorylated Epithelial Growth Factor Receptor and Activation of Nuclear Factor-Kappa B in Non-Small Cell Lung CancerNaohisa Chiba, Toshi Menju, Yumeta Shimazu, et al.Pageof 13